ID

32474

Descrição

Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01216527

Link

https://clinicaltrials.gov/show/NCT01216527

Palavras-chave

Versões (1)
  1. 02/11/2018 02/11/2018 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

2 de novembro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Squamous Cell Esophageal Carcinoma NCT01216527

Inglês

Eligibility Squamous Cell Esophageal Carcinoma NCT01216527

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histologic diagnosis of squamous cell thoracic esophageal carcinoma of stage iib or iii, which is potentially resectable.
Descrição

Squamous cell carcinoma of esophagus Thoracic Resectable TNM clinical staging

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0279626
UMLS CUI [1,2]
C0817096
UMLS CUI [1,3]
C1514888
UMLS CUI [1,4]
C3258246
2. patients must not have received any prior anticancer therapy.
Descrição

Cancer treatment Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0332197
3. more than 6 months of expected survival.
Descrição

Life Expectancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023671
4. age ranges from 18 to 70 years.
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
5. absolute white blood cells count ≥4.0×109/l, neutrophil ≥1.5×109/l, platelets
Descrição

White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0032181
≥100.0×109/l, hemoglobin ≥90g/l, and normal functions of liver and kidney.
Descrição

Hemoglobin measurement | Liver function | Renal function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
6. karnofsky performance status (kps) of 90 or more.
Descrição

Karnofsky Performance Status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0206065
7. signed informed consent document on file.
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients are diagnosed or suspected to be allergic to cisplatin or vinorelbine.
Descrição

Cisplatin allergy | Cisplatin allergy Suspected | Hypersensitivity Vinorelbine | Hypersensitivity Suspected Vinorelbine

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0570702
UMLS CUI [2,1]
C0570702
UMLS CUI [2,2]
C0750491
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0078257
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0078257
2. patients with concomitant hemorrhagic disease.
Descrição

Hemorrhagic Disorder

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019087
3. pregnant or breast feeding.
Descrição

Pregnancy | Breast Feeding

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
4. inability to use gastric conduit after esophagectomy because of a prior surgery.
Descrição

Use of Conduit gastric Unable | Status post Esophagectomy | Etiology Operative Surgical Procedures Previous

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1524063
UMLS CUI [1,2]
C0441247
UMLS CUI [1,3]
C0038351
UMLS CUI [1,4]
C1299582
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0085198
UMLS CUI [3,1]
C0015127
UMLS CUI [3,2]
C0543467
UMLS CUI [3,3]
C0205156
5. patients with concomitant peripheral neuropathy, whose ctc status is 2 or even more.
Descrição

Peripheral Neuropathy CTCAE Grades

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
6. have a prior malignancy other than esophageal carcinoma, carcinoma in situ of the cervix, nonmelanoma skin cancer or cured early stage of prostate cancer.
Descrição

Malignant Neoplasms | Exception Esophageal carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Skin carcinoma | Exception Prostate carcinoma Early stage Cured

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0152018
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0699893
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0600139
UMLS CUI [5,3]
C2363430
UMLS CUI [5,4]
C0679252
Voltar ao início da página

Similar models

Eligibility Squamous Cell Esophageal Carcinoma NCT01216527

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Squamous cell carcinoma of esophagus Thoracic Resectable TNM clinical staging
Item
1. histologic diagnosis of squamous cell thoracic esophageal carcinoma of stage iib or iii, which is potentially resectable.
boolean
C0279626 (UMLS CUI [1,1])
C0817096 (UMLS CUI [1,2])
C1514888 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
Cancer treatment Absent
Item
2. patients must not have received any prior anticancer therapy.
boolean
C0920425 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Life Expectancy
Item
3. more than 6 months of expected survival.
boolean
C0023671 (UMLS CUI [1])
Age
Item
4. age ranges from 18 to 70 years.
boolean
C0001779 (UMLS CUI [1])
White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement
Item
5. absolute white blood cells count ≥4.0×109/l, neutrophil ≥1.5×109/l, platelets
boolean
C0023508 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Hemoglobin measurement | Liver function | Renal function
Item
≥100.0×109/l, hemoglobin ≥90g/l, and normal functions of liver and kidney.
boolean
C0518015 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Karnofsky Performance Status
Item
6. karnofsky performance status (kps) of 90 or more.
boolean
C0206065 (UMLS CUI [1])
Informed Consent
Item
7. signed informed consent document on file.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cisplatin allergy | Cisplatin allergy Suspected | Hypersensitivity Vinorelbine | Hypersensitivity Suspected Vinorelbine
Item
1. patients are diagnosed or suspected to be allergic to cisplatin or vinorelbine.
boolean
C0570702 (UMLS CUI [1])
C0570702 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0078257 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0078257 (UMLS CUI [4,3])
Hemorrhagic Disorder
Item
2. patients with concomitant hemorrhagic disease.
boolean
C0019087 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
3. pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Use of Conduit gastric Unable | Status post Esophagectomy | Etiology Operative Surgical Procedures Previous
Item
4. inability to use gastric conduit after esophagectomy because of a prior surgery.
boolean
C1524063 (UMLS CUI [1,1])
C0441247 (UMLS CUI [1,2])
C0038351 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
C0231290 (UMLS CUI [2,1])
C0085198 (UMLS CUI [2,2])
C0015127 (UMLS CUI [3,1])
C0543467 (UMLS CUI [3,2])
C0205156 (UMLS CUI [3,3])
Peripheral Neuropathy CTCAE Grades
Item
5. patients with concomitant peripheral neuropathy, whose ctc status is 2 or even more.
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Malignant Neoplasms | Exception Esophageal carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Skin carcinoma | Exception Prostate carcinoma Early stage Cured
Item
6. have a prior malignancy other than esophageal carcinoma, carcinoma in situ of the cervix, nonmelanoma skin cancer or cured early stage of prostate cancer.
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0152018 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0699893 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0600139 (UMLS CUI [5,2])
C2363430 (UMLS CUI [5,3])
C0679252 (UMLS CUI [5,4])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial